Loading organizations...
Based in New York, New York, BIO Protocol is a decentralized science network and onchain platform that enables patient communities, scientists, and investors to fund and co-own biomedical research. The organization operates by supporting a network of decentralized autonomous organizations, known as BioDAOs, to bring scientific intellectual property onchain via tokenized assets. The protocol currently provides liquidity, curation, and funding to a network of eight active BioDAOs that hold a combined market capitalization in the tens of millions of dollars. BIO Protocol has attracted strategic venture capital and institutional investments from recognizable corporate and financial entities including Pfizer, Binance Labs, and 1kx. Its ecosystem coordinates funding and governance for specific medical fields through affiliated network organizations such as VitaDAO and HairDAO. The platform was founded in 2022 by Paul Kohlhaas and Tyler Golato.
BIO Protocol has raised $6.9M across 1 funding round.
BIO Protocol has raised $6.9M in total across 1 funding round.
BIO Protocol has raised $6.9M in total across 1 funding round.
BIO Protocol's investors include Arthur Hayes, Animoca Brands, Big Brain Holdings, Foresight Ventures, Mechanism Capital, Mirana Ventures, Panga Capital, Zee Prime.
BIO Protocol has raised $6.9M across 1 funding round. Most recently, it raised $6.9M Seed in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 17, 2025 | $6.9M Seed | Arthur Hayes | Animoca Brands, BIG Brain Holdings, Foresight Ventures, Mechanism Capital, Mirana Ventures, Panga Capital, ZEE Prime | Announced |
